Business Context and Reporting Period
Maiden Holdings, Ltd. (MHLD), a Bermuda-based holding company, filed this Form 8-K on August 6, 2019, reporting events occurring on July 31, 2019. The filing details the completion of a series of strategic transactions designed to stabilize the company's capital position following challenging results in 2017 and 2018. The company is scheduled to report its financial results for the second quarter and six months ended June 30, 2019, on August 9, 2019.
Key Financial Metrics and Transaction Values
The filing outlines specific financial terms for several material agreements:
- Loss Portfolio Transfer/Adverse Development Cover (LPT/ADC): Maiden Bermuda transferred liabilities to Enstar Group Limited (via Cavello Bay Reinsurance Limited) for a premium of $445 million. The agreement covers loss reserves in excess of a $2.178 billion retention up to $600.0 million and provides $155.0 million in adverse development cover.
- Commutation Agreement: Maiden Bermuda commuted certain workers' compensation loss reserves to AmTrust Financial Services, Inc. (via AmTrust International Insurance Ltd.) for a net payment of $330.7 million (based on December 31, 2018 reserves, less $17.9 million in payments made in 2019).
- Interest Payments: Maiden expects to pay approximately $7.3 million in interest to Enstar and $6.1 million in interest to AmTrust related to the respective transactions, with funding settlement expected by August 12, 2019.
- MRNA Sale Resolution: The company recognized a net charge of $16.7 million in its results of operations for the three months ended June 30, 2019, related to the resolution of balances from the December 2018 sale of Maiden Reinsurance North America, Inc. (MRNA).
The filing does not provide current revenue, profit, cash flow, or debt totals, as these are expected in the upcoming 10-Q filing.
Material Changes and Strategic Actions
The company executed significant changes to its balance sheet and reinsurance structure:
- Capital Strengthening: Management states that the combined LPT/ADC and Commutation agreements have materially improved solvency ratios, now exceeding both minimum and target levels set by the Bermuda Monetary Authority (BMA).
- Agreement Modifications: The LPT/ADC was modified from a previously announced limit of $675 million for $500 million to a limit of $600 million for $445 million, covering only the AmTrust Quota Share Agreement.
- Collateral Adjustments: A Master Collateral Agreement (MCA) was entered into to coordinate collateral protection. The Post-Termination Endorsement to the AmTrust Quota Share Agreement increased the required funding percentage from 102% to 105% of obligations, with a minimum excess funding requirement of $54 million.
- Termination of Agreements: The company terminated an Excess of Loss Agreement dated December 27, 2018, and cancelled a $25 million excess of loss reinsurance contract related to the MRNA sale.
Outlook, Risks, and Management Commentary
Management views these transactions as a significant milestone in stabilizing the business and de-risking the balance sheet. CEO Lawrence F. Metz emphasized the commitment to advancing the company's recovery, while CFO Patrick J. Haveron noted that solvency ratios are expected to continue improving throughout 2019 as the capital required to operate declines.
Risks and Contingencies: The filing includes standard forward-looking statement disclaimers, citing risks such as non-receipt of expected payments, changes in interest rates, investment performance, claim developments, accuracy of loss reserve projections, regulatory changes, and unusual storm activity. The company notes that actual results may differ materially from projections.
Investor Verification Checklist
- Verify the impact of the $16.7 million net charge on the Q2 2019 earnings report expected on August 9, 2019.
- Confirm the exact timing of the $7.3 million and $6.1 million interest payments to Enstar and AmTrust, respectively.
- Review the upcoming Form 10-Q for updated solvency ratios and the specific effect of the $445 million premium and $330.7 million commutation on the balance sheet.
- Monitor the status of the Master Collateral Agreement and the 105% funding requirement to ensure no gaps in collateral funding occur.
- Assess the long-term implications of the modified loss corridor (capped at $40.5 million) on future liability exposure.